Implementing a Group Physical Therapy Program for Veterans (GroupPT): Function QUERI 3.0 (GroupPT)

Implementing a Group Physical Therapy Program for Veterans With Knee Osteoarthritis: Function QUERI 3.0 (QUE 25-008)

Implementing Group Physical Therapy for Veterans with Knee Osteoarthritis (Group PT): Function QUERI 3.0 aims to compare two implementation approaches for implementing Group PT in 20 VA facilities using a type III effectiveness-implementation hybrid study framework and parallel cluster randomized trial (CRT) design.

Study Overview

Detailed Description

Background/Purpose. Exercise-based PT is a key component of guideline concordant knee OA management. However, PT is underutilized for knee OA, resulting in missed opportunities to improve outcomes for the many Veterans with this health condition. A key challenge is the high demand for PT services for knee OA, paired with limited availability of PT services, which can lead to long wait times for Veterans or high community care costs for the VA. Group-based delivery of PT for knee OA can enhance access and efficiency. Following an RCT that supported the effectiveness of Group PT relative to individual PT, the Durham Veterans Affairs Healthcare System (DVAHCS) offered Group PT as a clinical service, and found that patients achieved clinically relevant improvements in pain and functional outcomes that were comparable to those observed in the RCT. Most recently, the investigators conducted a 19-site trial comparing implementation strategies to support delivery of Group PT in the VA. Overall, 16 sites successfully delivered a Group PT program, enrolling a total of 366 Veterans. There were clinically relevant improvements in pain interference and functional outcomes among participating Veterans.

The overall goal of this trial is to evaluate implementation of Group PT with a foundational arm versus the Reach Equity and Collective Health (REACH) arm.

Methodology. To evaluate implementation of Group PT, the investigators will randomize sites (n=20) 1:1 to either the foundational arm or the REACH arm. Implementation activities will occur over a 12-month period. The Group PT program includes 6 sessions that include exercise and educational content. Patients will be eligible for Group PT if they have a clinician diagnosis of symptomatic knee OA and ineligible if they have a substantial fall risk or co-occurring health conditions that would make participation in a group exercise class unsafe. The primary follow-up outcome time-point will be 18 months; metrics will also be evaluated at 12 months (reach, patient engagement). Implementation outcomes include 1) Reach (primary), defined as the number of patients initiating Group PT, 2) Patient Engagement, defined as the average number of sessions attended by patients who initiate the EBP, and 3) Time to Adoption, defined as the time from baseline to launching a Group PT program and enrolling 5 Veterans. Generalized linear models will be used to examine the effect of Foundational vs. REACH arms on reach and patient engagement.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705-3875
        • Recruiting
        • Durham VA Medical Center, Durham, NC
        • Contact:
        • Principal Investigator:
          • Kelli Dominick Allen, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Sites are eligible to participate if they have:

  • 2 outpatient PT clinicians (one primary and one back-up) for delivering Group PT
  • space to conduct group sessions (if delivering Group PT in person) or ability to conduct visits via telehealth (video)

Patients will be eligible for Group PT if they have a clinician diagnosis of symptomatic knee OA.

Exclusion Criteria:

  • Site will be ineligible to participate if they are already conducting a group physical therapy class for patients with knee OA.
  • Patients will be ineligible for Group PT if they have a substantial fall risk or co-occurring health conditions that would make participation in a group exercise class unsafe.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: REACH (Reach Equity And Collective Health) Arm
The REACH Arm will include the same activities as the foundational arm plus REACH activities: 1) external facilitation and 2) equity-focused data-driven monitoring.
The REACH Arm includes everything in the Foundational Arm, plus additional components: targeted data reports and external facilitation.
Active Comparator: Foundational Arm
Foundational Arm uses the Replicating Effective Program (REP) implementation strategy and includes 3 elements that were developed and tested in our prior Function QUERI work: program initiation, self-guided resources, and technical assistance.
The Foundational Arm includes the following activities: Toolkit, kickoff call, SharePoint, TEAMS channel, office hours calls, site specific data reports.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reach
Time Frame: 18 months
Reach will be defined as the number of patients initiating (completing the first session of) Group PT at a site.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reach
Time Frame: 12 months
Reach will be defined as the number of patients initiating (completing the first session of) Group PT at a site.
12 months
Time to Adoption
Time Frame: 18 months
Time to Adoption will be defined as the time from baseline to the time at which a site crosses the adoption threshold (Adoption will be defined as launching a Group PT program and having ≥5 Veterans initiate Group PT). This will be computed for each site meeting the adoption criteria.
18 months
Patient Engagement
Time Frame: 12 months
Patient engagement will be defined as the average number of sessions attended by patients who initiate Group PT at a site.
12 months
Patient Engagement
Time Frame: 18 months
Patient engagement will be defined as the average number of sessions attended by patients who initiate Group PT at a site.
18 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS Pain Interference
Time Frame: 6 months
A self-reported measure that captures the consequences of pain on relevant aspects of life, including engagement with social, cognitive, emotional, physical, and recreational activities. Lower scores are better, indicating less pain interference. The investigators will use the PROMIS v1.1 Pain Interference Short form 4a.
6 months
PROMIS Physical Function
Time Frame: 6 months
A self-reported measure that captures the difficulty of performing instrumental activities of daily living. Higher scores are better, indicating more physical function. The investigators will use the PROMIS Short form 4a PROMIS v2.0 Physical Function Short form 4a.
6 months
PROMIS Pain Interference
Time Frame: 12 months
A self-reported measure that captures the consequences of pain on relevant aspects of life, including engagement with social, cognitive, emotional, physical, and recreational activities. Lower scores are better, indicating less pain interference. The investigators will use the PROMIS v1.1 Pain Interference Short form 4a.
12 months
PROMIS Pain Interference
Time Frame: 18 months
A self-reported measure that captures the consequences of pain on relevant aspects of life, including engagement with social, cognitive, emotional, physical, and recreational activities. Lower scores are better, indicating less pain interference. The investigators will use the PROMIS v1.1 Pain Interference Short form 4a.
18 months
PROMIS Physical Function
Time Frame: 12 months
A self-reported measure that captures the difficulty of performing instrumental activities of daily living. Higher scores are better, indicating more physical function. The investigators will use the PROMIS Short form 4a PROMIS v2.0 Physical Function Short form 4a.
12 months
PROMIS Physical Function
Time Frame: 18 months
A self-reported measure that captures the difficulty of performing instrumental activities of daily living. Higher scores are better, indicating more physical function. The investigators will use the PROMIS Short form 4a PROMIS v2.0 Physical Function Short form 4a.
18 months
30-second Chair Stand Test
Time Frame: 6 months
Number of times patient can stand up from a seated position and sit back down within 30 seconds.
6 months
30-second Chair Stand Test
Time Frame: 12 months
Number of times patient can stand up from a seated position and sit back down within 30 seconds.
12 months
30-second Chair Stand Test
Time Frame: 18 months
Number of times patient can stand up from a seated position and sit back down within 30 seconds.
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kelli Dominick Allen, PhD, Durham VA Medical Center, Durham, NC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2026

Primary Completion (Estimated)

September 30, 2030

Study Completion (Estimated)

September 30, 2030

Study Registration Dates

First Submitted

October 6, 2025

First Submitted That Met QC Criteria

October 6, 2025

First Posted (Actual)

October 10, 2025

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 1, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A de-identified, anonymized dataset will be available upon request. Prior to distribution, a local privacy officer and study statistician will certify that the dataset contains no protected health information (PHI). Data will be provided to requestor in electronic format. Sufficient data and descriptors will be made available to duplicate statistical analysis and confirm conclusions in publication. No data or statistical code that could lead to re-identification of individuals will be released. Data will be stored & maintained in an approved, secured location as described in the VA Research Data Inventory Form. The statistician will create de-identified, publication-specific datasets that include variables from statistical models presented in publication. Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re-identify any individual whose data is included in the dataset.

IPD Sharing Time Frame

Available upon request.

IPD Sharing Access Criteria

Data will only be released per appropriate authorizations or agreements. Written agreements will specify that recipients are prohibited from taking steps to re- identify any individual whose data are included in the dataset.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe